Skip to main content
Clinical Trials/ISRCTN47787339
ISRCTN47787339
Completed
Phase 4

Does intravenous lidocaine reduce the need for alfentanil during colonoscopy under procedural sedation and analgesia?

Radboud Universitair Medisch Centrum0 sites76 target enrollmentFebruary 25, 2019

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Healthcare domain: procedural sedation and analgesia (PSA)
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
76
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2020 Results article in https://doi.org/10.21203/rs.3.rs-50910/v1 (added 22/08/2022)

Registry
who.int
Start Date
February 25, 2019
End Date
November 27, 2018
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Colonoscopy performed under PSA
  • 2\. Age 18\-65 years
  • 3\. Inflammatory bowel disease: Crohn’s disease or ulcerative colitis
  • 4\. Informed consent
  • 5\. ASA classification 1 or 2

Exclusion Criteria

  • 1\. Pregnancy
  • 2\. Emergency colonoscopy
  • 3\. Allergies for study medication
  • 4\. Rhythm disorders i.e. first, second or third degree AV block
  • 5\. Brugada syndrome
  • 6\. Cardiomyopathy
  • 7\. BMI \>35
  • 8\. BMI \<18
  • 9\. Obstructive sleep apnea syndrome
  • 10\. Uncontrolled hypertension

Outcomes

Primary Outcomes

Not specified

Similar Trials